focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

12 Oct 2007 07:30

Amphion Innovations PLC12 October 2007 12 October 2007 Amphion innovations plc Proposed issue of 15,909,077 New Ordinary Shares and notice of Extraordinary General Meeting London and New York, 12 October 2007- Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announces its intention to raise approximately £3.5 million (before expenses) by the issue of up to 15,909,077 New Ordinary Shares of 1p each in the capital of the Company (the "New Ordinary Shares") to investors by way of subscription and placing for an issue price of 22 pence per New Ordinary Share (the "Issue Price") to enable the Company to invest in current and new Partner Companies and to provide working capital for the Company. The New Ordinary Shares will represent approximately 14.45 per cent of the Existing Amphion Share Capital. As part of the Issue, the Company has entered into the Subscription Agreementswith several investors who have between them agreed with the Company tosubscribe on a conditional basis for an aggregate of 15,022,727 New OrdinaryShares at the Issue Price raising approximately £3,305,000 (before expenses).This includes a subscription by the Chief Executive, Richard Morgan, for 760,714New Ordinary Shares. Subject to approval at the EGM Richard Morgan will have abeneficial interest in 20,862,327 Ordinary Shares in the Company being 16.55 percent. of the enlarged issued share capital of the Company. As part of theSubscription, MSA, which is 50 per cent. owned by Amphion, has committed tosubscribe £577,823 for 2,626,468 New Ordinary Shares at the Issue Price. TheSubscription Agreements are conditional upon the passing of the SpecialResolution at the Extraordinary General Meeting and Admission. In addition to the subscription agreements, Charles Stanley has conditionallyagreed pursuant to the Placing Agreement to place 886,350 New Ordinary Shares atthe Issue Price, raising approximately £195,000 (before expenses). CharlesStanley's obligations under the Placing Agreement are conditional, inter alia,upon the passing of the Special Resolution at the Extraordinary General Meetingand Admission. As a result of the above, and to enable the Company to implement the Issue on anon-pre-emptive basis, it is necessary for the Company to approve the Issuebeing made otherwise than in accordance with the Pre-emption Provisions by wayof a special resolution at an Extraordinary General Meeting. Subject to approval at the EGM the enlarged number of shares in issue will beapproximately 126,019,301 Ordinary Shares. Further Issues The Company has to date granted options to employees and Directors under theShare Option Scheme in respect of 125,000 Ordinary Shares. The Company is nowproposing to grant options in respect of a further 7,750,000 Ordinary Shares atan issue price of 23 pence per Ordinary Share to certain employees and Directorsunder the terms of the Share Option Scheme. This will include options in respectof 2,000,000 Ordinary Shares granted to Richard Morgan and in respect of1,250,000 Ordinary Shares granted to Robert Bertoldi. Authority for theallotment of Ordinary Shares under the Share Option Scheme has already beengiven by the Shareholders in general meeting. In addition, the Company wishes to have some flexibility to permit furtherissues of Ordinary Shares for cash otherwise than in accordance with thePre-emption Provisions and also to be able to grant options to service providersto the Company in consideration for services provided to the Company. Suchoptions are not granted to employees or Directors and, accordingly, fall outsidethe Share Option Scheme. In order to ensure that the Pre-emption Provisions do not apply to such furtherissues of Ordinary Shares for cash or to the allotment of any Ordinary Sharesfor cash following the exercise of options granted to such service providers,authority is now being sought for the allotment for cash of a further 12,600,000Ordinary Shares (representing approximately 10 per cent. of the Ordinary Sharesin issue immediately following the Issue) (the "Additional Shares"), otherwisethan in accordance with the Pre-emption Provisions, in the Special Resolution atthe Extraordinary General Meeting. Extraordinary General Meeting A circular to shareholders containing a notice of Extraordinary General Meetingof the Company is to be held on 5 November 2007 at Amphion's offices at OneBerkeley Street, London W1J 8DJ at 11.00 a.m. at which the Special Resolutionwill be proposed and voted upon for the purposes of facilitating the Issue ofNew Ordinary Shares. The Special Resolution will, if passed, disapply the Pre-emption Provisionscontained in Article 5.1 of the Articles in relation to the issue of the NewOrdinary Shares pursuant to the Issue and, in addition to the the allotment ofthe Additional Shares. It is expected that admission of the New Ordinary Shares to trading on AIM willbecome effective and dealings, for normal settlement, will commence on 6November 2007. The New Ordinary Shares will be eligible for settlement throughCREST. Whether or not they propose to attend the Extraordinary General Meeting, AmphionShareholders are requested to complete and sign the Form of Proxy and return itby post or (during normal business hours) by hand to Amphion's registered officeat 15-19 Athol Street, Douglas, Isle of Man IM1 1LB as soon as possible and, inany event, so as to arrive no later than 48 hours before the time of theExtraordinary General Meeting. Further information is contained in the Circularto Shareholder dated 12 October 2007. The Board considers that the proposals asset out in the Circular are in the best interests of the Company and theShareholders as a whole. Accordingly, the Board unanimously recommends allShareholders to vote in favour of the Special Resolution at the forthcomingExtraordinary General Meeting as they have irrevocably undertaken to do inrespect of the 48,771,122 Ordinary Shares registered in their own names(representing approximately 44.29 per cent. of the Existing Amphion ShareCapital). Amphion's Chief Executive Officer, Richard C.E. Morgan, said: "As we said in our interim statement in September, Amphion has had a promisingfirst half of the year, reporting a 35.7per cent. rise in net asset value pershare and 48 per cent. increase in the fair value of our portfolio. These newfunds raised will enable us to continue this strong progress within our currentPartner Companies and also allow us to seek new opportunities where we feelthere is significant opportunity for growth and shareholder return." For further information, please contact: Amphion Innovations plc +1 212 210 6224Charlie Morgan Financial Dynamics +44 20 7831 3113Ben AtwellJohn Gilbert Charles Stanley Securities (Nominated Adviser) +44 20 7149 6000Mark Taylor / Freddy Crossley This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Dec 20097:01 amRNSFunding & IP Licensing Updates
25th Nov 20097:00 amRNSAmphion Partnership with Kuwait University
30th Oct 20095:11 pmRNSTotal Voting Rights
16th Oct 20092:37 pmRNSDirector/PDMR Shareholding
6th Oct 20098:59 amRNSPartner Company Wellgen Release
21st Sep 20092:41 pmRNSDirector/PDMR Shareholding
20th Aug 20097:00 amRNSHalf Yearly Report
25th Jun 20097:00 amRNSIP License Agreements
4th Jun 20097:00 amRNSAGM Statement
14th May 20095:26 pmRNSAnnual Financial Report
13th May 20095:29 pmRNSIssue of Equity
5th May 20097:00 amRNSIP License Agreements
1st May 20097:00 amRNSDirectorate Change
30th Apr 20095:05 pmRNSTotal Voting Rights
7th Apr 20093:54 pmRNSDirector/PDMR Shareholding
26th Mar 20093:47 pmRNSDirector/PDMR Shareholding
16th Mar 20097:00 amRNSFinal Results
4th Mar 200910:51 amRNSNotice of Results
27th Feb 20094:46 pmRNSDirector Dealings
27th Feb 20091:20 pmRNSAmphion Partner AXCESS International Wins Contract
30th Jan 20097:00 amRNSFunding Update
19th Jan 20097:00 amRNSTrading Statement
31st Dec 20087:00 amRNSConvertible Promisory Note Offering
27th Nov 20087:00 amRNSPartner Company Announces IP License Agreement
31st Oct 20083:46 pmRNSTotal Voting Rights
28th Oct 20087:00 amRNSNew CEO for Partner Company
23rd Oct 20087:00 amRNSDirector/PDMR Shareholding
17th Oct 20087:00 amRNSPartner Company Announces IP Licence Agreement
17th Sep 20087:00 amRNSPartner Company - Product Launch
16th Sep 20087:14 amRNSDirector/PDMR Shareholding
18th Aug 20087:00 amRNSInterim Results
1st Aug 20089:00 amRNSNotice of Interim Results
17th Jun 20082:54 pmRNSDirector/PDMR Shareholding
12th Jun 20087:00 amRNSAGM Statement
10th Jun 20087:00 amRNSPartner Company Announces IP
27th May 20087:00 amRNSDSC Fundraising
23rd May 20087:00 amRNSFundraising for Partner Compa
30th Apr 20082:58 pmRNSTotal Voting Rights
8th Apr 20087:00 amRNSPartner Company Fundraising
7th Apr 20083:46 pmRNSFundraising
26th Mar 200812:36 pmRNSDirector/PDMR Shareholding
13th Mar 20087:12 amRNSFinal Results
3rd Mar 20087:01 amRNSPrivateMarkets Fundraising
27th Feb 20088:00 amRNSNotice of Preliminary Results
31st Jan 20084:51 pmRNSTotal Voting Rights
17th Jan 20087:01 amRNSTrading Statement
7th Jan 20087:00 amRNSDirectors Dealings
30th Nov 20074:53 pmRNSTotal Voting Rights
12th Nov 20077:01 amRNSIssue of Equity
5th Nov 20071:59 pmRNSResult of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.